Searched for
TEVA PHARMACEUTICALS
Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages saySun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in...- US charges Teva Pharmaceutical Industries Ltd in generic drugs price-fixing probeThe Justice Department has been investigating allegations the company colluded with other drugmakers to push up the prices of widely used p...
- Teva appoints Dipankar Bhattacharjee as Prez, CEO Global Generic GroupAs President and CEO of Teva Generics Europe, Bhattacharjee has a proven track record of improving revenues and profitability, significantl...
- Teva Pharmaceutical inks largest realty deal for HQ at GoregaonThe drug-maker will be paying Rs 140-145 per sq ft per month for the space. Teva has leased the front-office space for five years and renta...
- DRL, Cipla, Aurobindo among others to buy products from TevaThe remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...
- Teva-Allergan deal a booster for Indian companiesTeva Pharmaceutical Industries’ $40.5-billion purchase of Allergan’s generics business may help Indian generic-drug makers acquire products
- Israel's Teva buys Allergan generic drug company for $40.5 billionTeva Pharmaceutical Industries Ltd. says it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion.
- Mylan rejects Teva's $40 billion merger offer as undervaluedDrug major Mylan has rejected a $40 billion unsolicited merger offer from Israel's Teva Pharmaceutical Industries calling the bid undervalu...
- Cipla signs pact with Teva Pharmaceuticals for selling drugs in South AfricaThe collaboration will focus on oncology, central nervous system, women's health, cardiovascular, ophthalmology and other speciality produc...
- Cipla Medpro collaborates with Teva Pharma; stock gainsThe collaboration is a sales and distribution arrangement whereby Cipla Medpro will exclusively sell Teva’s broad pharmaceutical product po...
- Teva settles patent dispute with Orchid PharmaTeva has settled patent dispute with Orchid Chemicals & Pharma pertaining to Parkinson’s disease drug Azilect (rasagiline mesylate) in the ...
- Israel's Teva Pharmaceutical Industries to foray into India through JV with Proctor & GambleGlobal pharma giant, Teva Pharmaceutical Industries (TPI) shall foray into India through a joint venture with US based Proctor & Gamble (P&...
- Natco Pharma loses patent case against Teva Pharmaceutical Industries of anti-sclerosis drugNatco Pharma has lost a patent litigation against Israel's Teva Pharmaceutical Industries in the US over multiple sclerosis treatment drug,...
- Teva Pharmaceuticals will not be launching Atorvastatin, generic version of LipitorIsrael's Teva Pharmaceuticals will not launch atorvastatin, the generic version of Lipitor, that will help Indian cos Ranbaxy and Dr Reddy'...
- Jeremy Levin named as next CEO of Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries Ltd named Jeremy Levin of Bristol-Myers Squibb Coto to replace Shlomo Yanai as chief executive officer.
- Teva to buy Taiyo stake for $460 million, bid for restTeva Pharmaceutical Industries Ltd agreed to buy 57% of Taiyo Pharmaceutical Industry Co Ltd. for $460 million and bid for the rest.
- Zydus drags Teva to court for antitrust violationsZydus Cadila, an Ahmedabad-based pharmaceutical company, has taken Teva Pharmaceuticals, the world’s largest generic drug maker, to court i...
- Teva to buy Barr Pharma for $7.5 bnIn the latest drug consolidation, Teva Pharmaceutical said on Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7...
- Flamingo expands CRAM pact with Israel co TevaMumbai-based Flamingo Pharmaceuticals has expanded its CRAM (contract research and manufacturing) agreement with Israel’s Teva Pharmaceutic...
- Israel's Teva moves court against Indian cos for patent violationIsrael’s Teva Pharmaceutical Industries Ltd has moved court against five leading Indian companies - Cipla, Zydus Cadila Healthcare, Lupin, ...
Load More
